| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/28/2008 | US20080206292 Cosmetic Method for Targeting of Wrinkles |
| 08/28/2008 | US20080206281 Method For Producing Storage Stable Viruses and Immunogenic Compositions Thereof |
| 08/28/2008 | US20080206223 Treatment of pompe's disease |
| 08/28/2008 | US20080206163 INHIBITORS OF PHOSPHODIESTERASE (PDE) ISOENZYMES; USEFUL FOR TREATMENT OF RESPIRATORY DISORDERS SUCH AS ASTHMA; chronic obstructive pulmonary disease (COPD); 9,10-Dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one |
| 08/28/2008 | US20080206162 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses |
| 08/28/2008 | US20080206161 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions |
| 08/28/2008 | US20080206160 Antimicrobial protein cecropin B, and exhibit cell stimulatory, migratory and antiinflammatory properties; preventing and reversing skin surface damage; wound healing include abrasions, blisters, burns, lacerations, ulcers, bruises, rashes, scars, and the effects of aging |
| 08/28/2008 | US20080206159 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions |
| 08/28/2008 | US20080206158 1-(4-methoxyphenyl)-vinyl 4-tert-butylbenzoate; cosmetic, pharmaceutical, personal care and industrial preparations as sunscreens; ultraviolet radiation protection |
| 08/28/2008 | US20080206157 Using NO source like nitrosoguanidine, glycerol trinitrate, isoamyl nitrite; cerebral disorders; |
| 08/28/2008 | US20080206156 Continuous spray scalp therapy and dispensing systems for same |
| 08/28/2008 | US20080206155 Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| 08/28/2008 | US20080206153 Copolymer made using a molecular weight regulator having at least three functional regulating groups, such as trimethylolpropane tris(2-mercaptopropionate) (TMPTMP); e.g. TMPTMP modified ethyl acrylate-methacrylic acid-tert-butyl acrylate terpolymer; hair sprays; film forming, low viscosity formulations |
| 08/28/2008 | US20080206151 Magnetic resonance imaging (MRI) contrast agent; synthesis by reacting acid-functional group with phosphoethanolamine and then with a peptide; amine containing phospholipids with functional groups in the liposome membrane that are useful as sites for binding |
| 08/28/2008 | US20080206146 Capable of crossing the blood brain barrier and having differential affinity for a tissue in the brain, such as diseased tissue; diagnosis; drug screening with animal model |
| 08/28/2008 | US20080206139 Nanovesicles specifically targeted to abnormal cells; tissue-targeted therapy; central nervous system disorders such as astrocytoma; tumor-targeting therapy |
| 08/28/2008 | US20080206130 In vivo panning for ligands to radiation-induced molecules |
| 08/28/2008 | US20080202967 Treatment pad comprising hydrophilic polymer consisting of polyvinyl alcohol, polyoxyethylene glycol, polyacrylamide, polyacrylic acid, polyhydroxyethyl methacrylate, and/or polyoxyethylene glycol; preservatives and water; self-supporting; for eyes or surrounding tissue; containers conjoined by hinges |
| 08/28/2008 | US20080202684 Wood adhesives containing solid residues of biomass fermentations |
| 08/28/2008 | US20080202513 Use of Dry Powder Compositions For Pulmonary Delivery |
| 08/28/2008 | DE112006002618T5 Verfahren und Zusammensetzungen zum selektiven Entfernen von Kaliumionen aus dem Gastrointestinaltrakt eines Säugers Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| 08/28/2008 | DE112006002617T5 Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite Process for the preparation of core-shell composites or core-shell composites with networked cases and resulting core-shell composites |
| 08/28/2008 | CA2679016A1 Solid pharmaceutical and vaccine dose |
| 08/28/2008 | CA2679010A1 Pellets comprising an active substance matrix resistant to gastric juice |
| 08/28/2008 | CA2678956A1 Method of determining the weight of the coating to be applied to form a controlled release dosage form |
| 08/28/2008 | CA2678706A1 Composition for combating epistaxis |
| 08/28/2008 | CA2678677A1 Delta 9 - tetrahydrocannabinol processing |
| 08/28/2008 | CA2677989A1 Stable digestive enzyme compositions |
| 08/28/2008 | CA2677727A1 Pellets comprising an active substance matrix and a polymer coating, and a method for producing said pellets |
| 08/28/2008 | CA2677436A1 Composition for treatment of cartilage disease |
| 08/28/2008 | CA2623560A1 A process for preparing stable amorphous benzimidazole composition |
| 08/28/2008 | CA2622736A1 Drug containing adhesive preparation |
| 08/27/2008 | EP1961419A1 Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitor |
| 08/27/2008 | EP1961417A1 Bisoprolol-containing adhesive patch |
| 08/27/2008 | EP1961415A1 Adhesive preparation |
| 08/27/2008 | EP1961414A1 A controlled release composition comprising a recombinant gelatin |
| 08/27/2008 | EP1961413A1 Rapidly disintegratable oral tablet |
| 08/27/2008 | EP1961412A1 Self-microemulsifying drug delivery systems |
| 08/27/2008 | EP1961411A1 A controlled release composition |
| 08/27/2008 | EP1961409A2 Compressible solid particles, procedures for the obtention thereof, and procedures for the use of said solid particles in tablets for body cleansing |
| 08/27/2008 | EP1960415A2 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 08/27/2008 | EP1960412A2 Amphotericin b salt |
| 08/27/2008 | EP1959987A2 Mucosal delivery of stabilized formulations of exendin |
| 08/27/2008 | EP1959977A2 Compositions for regulating intestinal disorders and methods of use thereof |
| 08/27/2008 | EP1959974A2 Modifying leukocyte function |
| 08/27/2008 | EP1959966A2 Ganaxolone formulations and methods for the making and use thereof |
| 08/27/2008 | EP1959961A2 Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| 08/27/2008 | EP1959953A2 Stabilized pharmaceutical composition of pramipexole and method of preparation thereof |
| 08/27/2008 | EP1959941A1 Neramexane modified release matrix tablet |
| 08/27/2008 | EP1959938A2 Matrix-controlled transdermal system comprising salts of ace inhibitor dicarboxylic acids |
| 08/27/2008 | EP1959937A1 Transdermal therapeutic system |
| 08/27/2008 | EP1959936A2 Once-daily administration of central nervous system drugs |
| 08/27/2008 | EP1959935A2 Hydrophilic vehicle-based dual controlled release matrix system as capsule fill |
| 08/27/2008 | EP1959934A2 Bilayer tablet comprising telmisartan and diuretic |
| 08/27/2008 | EP1959933A1 Process for the perparation of lyophilized piperacilline sodium with improved stability after reconstitution |
| 08/27/2008 | EP1959932A2 Preparation of powders containing colloidal particles |
| 08/27/2008 | EP1959931A2 Compositions and methods for dermally treating pain |
| 08/27/2008 | EP1959929A2 Compositions and methods for treating dermatological conditions |
| 08/27/2008 | EP1959928A2 Spray-on formulations and methods for dermal delivery of drugs |
| 08/27/2008 | EP1959927A1 Composition in the form of a spray containing a corticoid and an oil phase |
| 08/27/2008 | EP1959926A1 Formulation comprising a drug of low water solubility and method of use thereof |
| 08/27/2008 | EP1959925A2 Controlled release microparticles |
| 08/27/2008 | EP1959924A2 Composition of fentanyl citrate oral solid transmucosal dosage form, dextrose monohydrate as major excipient and binding material therefor and methods of producing them |
| 08/27/2008 | EP1959923A2 Extended release pharmaceutical composition of metformin and a process for producing it |
| 08/27/2008 | EP1959922A2 Cosmetic compositions with encapsulated pigments and a method for using |
| 08/27/2008 | EP1959921A2 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 08/27/2008 | EP1959895A2 A layered dosage form for a medicated tampon assembly |
| 08/27/2008 | EP1959855A2 Benign prostate hyperplasia treatment using photosensitizer and laser ablation |
| 08/27/2008 | EP1959748A2 Encapsulated phospholipid-stabilized oxidizable material |
| 08/27/2008 | EP1796648A4 Flavored gelatin capsule and method of producing said capsule |
| 08/27/2008 | EP1748796A4 Multilayered nanomedicine delivery system and method |
| 08/27/2008 | EP1531814B1 Sustained-release tablet composition of pramipexole |
| 08/27/2008 | EP1455764B1 Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| 08/27/2008 | EP1450804B1 Pharmaceutical formulations comprising an immune response modifier |
| 08/27/2008 | EP1446504B1 Emulsion compositions |
| 08/27/2008 | EP1383386B1 Anti-inflammatory herbal composition |
| 08/27/2008 | EP1337262B1 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 08/27/2008 | EP1322665B1 Hiv peptides from conserved regions in gag p17 and their applications, such as vaccines |
| 08/27/2008 | EP1307188B1 Ajulemic acid for the treatment of cancer |
| 08/27/2008 | EP1240355B1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 08/27/2008 | EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 08/27/2008 | EP1015039B1 Oxygen delivery agents and uses for the same |
| 08/27/2008 | CN101253192A Antitumor agent |
| 08/27/2008 | CN101252940A Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases |
| 08/27/2008 | CN101252932A Trazodone composition for once a day administration |
| 08/27/2008 | CN101252923A Adhesive skin patch |
| 08/27/2008 | CN101252922A Antimicrobial materials |
| 08/27/2008 | CN101252921A Formulations of conjugated estrogens and bazedoxifene |
| 08/27/2008 | CN101252920A Stable fixed-dose unitary formulations containing tenofovir, a surfactant, efavirenz and emtricitabine |
| 08/27/2008 | CN101252919A Tablets with improved dissolution profile |
| 08/27/2008 | CN101252918A Oral drug compliance monitoring using sound detection |
| 08/27/2008 | CN101252917A Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily |
| 08/27/2008 | CN101252916A Improvements in the stabilisation of biological materials |
| 08/27/2008 | CN101252915A Pharmaceutical composition comprising perindopril or its salts |
| 08/27/2008 | CN101252914A Stable nanoparticle formulations |
| 08/27/2008 | CN101252913A Pharmaceutical composition comprising an iron chelator |
| 08/27/2008 | CN101252912A Liposome compositions |
| 08/27/2008 | CN101252911A Stabilized and preserved ketoifen ophthalmic compositions |
| 08/27/2008 | CN101252910A Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride |
| 08/27/2008 | CN101252909A Prolonged release formulations comprising anastrozole |